Canada markets closed

Kovo HealthTech Corporation (KOVO.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.03500.0000 (0.00%)
At close: 03:23PM EDT
Full screen
Previous Close0.0350
Open0.0350
Bid0.0350 x N/A
Ask0.0350 x N/A
Day's Range0.0350 - 0.0350
52 Week Range0.0200 - 0.1750
Volume52,000
Avg. Volume29,945
Market Cap2.014M
Beta (5Y Monthly)0.19
PE Ratio (TTM)N/A
EPS (TTM)-0.1200
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Newsfile

    Kovo Announces Q4 and Annual Results

    Vancouver, British Columbia--(Newsfile Corp. - May 13, 2024) - Kovo HealthTech Corporation (TSXV: KOVO) (the "Company" "Kovo") - a leader in healthcare technology and Billing-as-a-Service - today reported its annual financial results for the period ending December 31, 2023.Key Metrics:Securing a $3.3 million equity investment in April 2023.Securing a US$7.0 million credit facility in April 2023.Successful completion of the acquisition of E&A Medical Billing in April 2023.Completion of the acquis

  • Simply Wall St.

    Kovo HealthTech Full Year 2023 Earnings: US$0.09 loss per share (vs US$0.006 loss in FY 2022)

    Kovo HealthTech ( CVE:KOVO ) Full Year 2023 Results Key Financial Results Revenue: US$10.0m (down 5.0% from FY 2022...

  • Newsfile

    Kovo HealthTech Announces Signing of Forbearance Agreement with Its Primary Lender

    Vancouver, British Columbia--(Newsfile Corp. - April 3, 2024) - Kovo HealthTech Corporation (TSXV: KOVO) (the "Company" or "Kovo") - a leader in healthcare Billing-as-a-Service - announces a forbearance agreement with its primary lender Avonlea Ventures #2 Inc. ("AVI"), a corporation wholly-owned by Micheal Steele, a director of Kovo.Kovo's primary lender, AVI entered into a forbearance agreement (the "Forbearance Agreement") dated February 27th, 2024 in connection with the investment agreement